Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | Is the international physical activity questionnaire (IPAQ) a valid assessment tool for measuring physical activity of patients with axial spondyloartritis ? (2021) |
Auteurs : | Deniz Bayraktar ; Tugce Yuksel Karsli ; Derya Ozer Kaya ; Devrim Can Sarac ; Sercan Gucenmez ; Onay Gercik ; Gokhran Kabadayi ; Idil Kurut ; Dilek Solmaz ; Servet Akar |
Type de document : | Article |
Dans : | Musculoskeletal Science and Practice (Vol. 55, October 2021) |
Article en page(s) : | p. 1-5 |
Note générale : | doi:10.1016/j.msksp.2021.102418 |
Langues: | Anglais |
Descripteurs : |
HE Vinci Exercice physique |
Mots-clés: | Spondylarthrite axiale ; Accéléromètre ; international physical activity questionnaire (IPAQ) |
Résumé : |
Background:
Determining the level of physical activity (PA) is an essential part of patient evaluation in axial spondylarthritis (axSpA). Subjective and objective methods are both frequently used methods for evaluating PA. Although subjective methods are cost-effective and easy to use, their accuracy for measuring PA is still questionable. Objective: To investigate the concurrent criterion validity of a self-reported questionnaire (IPAQ-Short Form) when compared to an accelerometer (Actigraph wGT3X-BT) for measuring PA level in patients with axSpA. Design: Cross-sectional design. Methods: Fifty-eight patients with axSpA with a median age of 39.0 (IQR 25/75: 30.0/46.0) years were included in the study. An accelerometer (Actigraph wGT3X-BT) was attached to the waist of patients at their first visits and was removed at their second visits, seven days later. Patients were asked to complete the International Physical Activity Questionnaire Short Form (IPAQ) at their second visits. Results: No significant correlations were determined between IPAQ and accelerometer (p > 0.05), except for the moderate PA (rho: 0.367, p Conclusion: IPAQ might not be a valid tool for measuring PA level in patients with axSpA. Disease-specific subjective methods for determining the PA should be developed and validated for those patients. |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.sciencedirect.com/science/article/pii/S2468781221001028#! |